Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | |
| Buyback Open Date | July 15, 2022 |
| Buyback Closing Date | January 14, 2023 |
| Issue Size (Amount) | ₹60.00 Crores |
| Buyback Price | ₹60 per Share |
Marksans Pharma Ltd is coming up with BuyBack of the face value of ₹1 each, for an amount of ₹[.] Crores ('Base Issue Size') with an option to retain oversubscription up to ₹60.00 Crores.
Marksans Pharma Ltd. is an Indian pharmaceutical company engaged in the research, manufacturing and marketing of finished dosage pharmaceutical formulations. The company employs the latest technology, automated manufacturing and packing operations and best practices, ensuring the highest quality of healthcare.
The issue opens on Jul 15, 2022 and closes for subscription on Jan 14, 2023. The shares of the company to be list at BSE, NSE.
The public issue of Marksans Pharma Ltd opens on Jul 15, 2022 and closes for subscription on Jan 14, 2023.
The Marksans Pharma Buyback are proposed to list at BSE, NSE.
This page provides Buyback news of Marksans Pharma Buyback. The Marksans Pharma Buyback watch offers the latest Buyback issue news and keep you updated with the latest Buyback news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
